We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Hogan Lovells fields a life sciences department of considerable experience and reputation in the area, commended for its 'complete knowledge of the industry' and the counsel of choice for a plethora of major multinationals operating or investing in the Mexican market. Its impressively broad coverage -both domestically and abroad- includes work in pharmaceuticals and biotech, genetic engineering, medical devices, digital health, cannabis, cosmetics, food technology and general regulatory compliance. Recent work has included sensitive regulatory audits, major incident response in the chemicals industry, and litigation in the food industry. 'Leaders in the industry' Ernesto Algaba Reyes and Cecilia Stahlhut Espinosa co-lead the practice. Algaba Reyes draws on two decades of experience in the area and focuses his practice on health law and regulatory compliance for the pharmaceutical and medical devices industries. Raised to the partnership in January 2024, Stahlhut Espinosa has extensive experience in drug regulatory law, as well as in structuring regulatory strategy in a range of other industries.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Hogan team knows and understands the company's business, so they fully specify what we need. The team is diverse and inclusive and that helps to have different perspectives when it comes to the legal assessment that is needed.'
‘Experience on the subject is a plus since we usually work with highly regulated products and Cecilia is capable of solving and giving complete advice addressing the needs of the business.’
Key clients
- Vertex Pharmaceuticals
- MacDermid